These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29531778)

  • 1. Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis.
    Lai LYH; Harris E; West RM; Mackie SL
    RMD Open; 2018; 4(1):e000521. PubMed ID: 29531778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
    Sharma A; Mohammad AJ; Turesson C
    Semin Arthritis Rheum; 2020 Oct; 50(5):1040-1048. PubMed ID: 32911281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L; Betrains A; Boeckxstaens L; Molenberghs G; Van Laere K; De Langhe E; Vanderschueren S; Blockmans D
    Semin Arthritis Rheum; 2024 Oct; 68():152499. PubMed ID: 38968729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice.
    Craig G; Knapp K; Salim B; Mohan SV; Michalska M
    Rheumatol Ther; 2021 Mar; 8(1):529-539. PubMed ID: 33638132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
    BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
    Nielsen AW; Frølund LL; Våben C; Bonde AR; Gormsen LC; de Thurah AL; Hauge EM; Keller KK
    Semin Arthritis Rheum; 2022 Oct; 56():152069. PubMed ID: 35858507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
    Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
    Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
    Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
    Front Immunol; 2019; 10():1981. PubMed ID: 31507597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica-a repeated imaging study.
    Nielsen AW; Hauge EM; Hansen IT; Nielsen BD; Kjær SG; Blegvad J; Rewers K; Møller Sørensen C; Gormsen LC; Keller KK
    Rheumatology (Oxford); 2024 Aug; ():. PubMed ID: 39180419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
    Ungprasert P; Sanguankeo A; Upala S; Knight EL
    Semin Arthritis Rheum; 2014 Dec; 44(3):366-70. PubMed ID: 25074657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
    Singh JA; Cleveland JD
    Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
    Crowson CS; Matteson EL
    Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.